Year: 2026
Type: preprint
Abstract: Anti-tuberculosis (TB) immunity typically emphasizes CD4⁺ and CD8⁺ T cells that only provide limited protection against Mycobacterium tuberculosis ( Mtb ) infection. The anti-TB function of CD4 + CD8 + T cells remains unexplored, mostly due to the dogma that ThPOK and Runx3 antagonize each other to block their development and their scarcity. Here, we show that immunization of BCG (Bacillus Calmette–Guérin) with Complete Freund’s Adjuvant (CFA) markedly induced CD4 + CD8 + T cells through the gut microbiota Clostridium butyricum or its metabolite maleic acid. Mtb -specific CD4 + CD8 + T cells exhibited a broad T-cell receptor repertoire and sterilized Mtb infection by inducing SLAMF1 and neutrophil responses. Mechanistically, maleic acid interacted with PAK2 to promote STAT5 phosphorylation at Ser127, thus upregulating Ets1 expression. Direct binding of Ets1 to the Runx3 and ThPOK promoters orchestrated their expression to redirect the CD8 + T-cell differentiation towards the CD4 + CD8 + lineage. Moreover, immunization of BCG plus Clostridium butyricum or maleic acid sterilized Mtb infection in mouse models. These findings establish CD4 + CD8 + T cells as superior immune effectors against Mtb , a concept that could fundamentally redirect the current paradigm for anti-TB vaccine development.
Authors: Chenyue Shi, Hongyu Cheng, Xiaoli Feng, Xinyu Cao, Hongjie Liu, Qi Liu, Lu Zhang, Yuanna Cheng, Cheng Peng, Jinya Zhang, Qiaojiang Yang, Kejing Dong, Yuli Gao, Xinyi Hu, Yudan Liu, Yuhan Bian, Shenzhi Li, Yifan Yang, Lin Wang, Jie Wang, Xiaochen Huang, Xia Cai, Di Qu, Minghua Li, Hua Yang, Baoxue Ge
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7213981981
